kat: a high-efficiency retroviral transduction system for primary human T lymphocytes

Area of Science:

• Molecular Biology
• Virology
• Gene Therapy

Background:

• Traditional retroviral packaging systems often require generating stable producer clones, which can be time-consuming.
• Achieving high titers of amphotropic retrovirus and efficient transduction of primary cells remains a challenge.

Purpose of the Study:

• To develop a novel, transient retroviral packaging system for high-titer amphotropic retrovirus production.
• To evaluate the efficiency of this system in transducing primary human CD8+ T lymphocytes and other hematopoietic cells.

Main Methods:

• Utilized 'kat' expression vectors for high retroviral vector transcript and packaging function production.
• Transfected 293 cells with 'kat' plasmids and harvested virus 48 hours post-transfection.
• Assessed viral titers and transduction efficiencies in 3T3 cells and primary human CD8+ T lymphocytes.

Main Results:

• Achieved viral titers up to 3.8 proviral copies/cell/mL, significantly higher than transient titers from traditional packaging lines.
• Demonstrated transduction efficiencies of 10% to 40% in primary human CD8+ T lymphocytes, outperforming a high-titer PA317 producer clone.
• Confirmed the absence of replication-competent retrovirus, ensuring safety comparable to stable packaging lines.

Conclusions:

• The 'kat' virus production system enables rapid generation of high-titer retroviral supernatants.
• This system offers superior transduction efficiency for hematopoietic cell types, including those typically refractory to retroviral vectors.
• The novel system provides a safe and efficient alternative for retroviral vector production and gene delivery applications.